Targeted treatment approaches in refractory germ cell tumors

Simple item page
dc.centroFacultad de Medicinaes_ES
dc.contributor.authorGálvez Carvajal, Laura
dc.contributor.authorSánchez-Muñoz, Alfonso
dc.contributor.authorRibelles, Nuria
dc.contributor.authorSaez, Maribel
dc.contributor.authorBaena, Javier
dc.contributor.authorRuiz, Sofía
dc.contributor.authorIthurbisquy, Catherine
dc.contributor.authorAlba-Conejo, Emilio
dc.date.accessioned2024-05-10T09:56:27Z
dc.date.available2024-05-10T09:56:27Z
dc.date.created2024
dc.date.issued2019
dc.departamentoMedicina y Dermatología
dc.descriptionEste artículo ha sido publicado en la revista Crit Rev Oncol Hematology This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed. Les adjunto articulo y la respuesta de la revista si lo necesitan les puede hacer llegar toda la cadena de e mail Dear Dr. Alfonso sanchez muñoz, Thank you for the email. I could see that this is a published article (ONCH 2813). Below is the link to the published final version. Targeted treatment approaches in refractory germ cell tumors - ScienceDirect When you click this link, it would take you to the article in science direct, there you could see a link named "Get rights and content" Appended below is the screenshot. Please use this link to get all rights for this published article.es_ES
dc.description.abstractGerm cell tumors (GCTs) are the most common type of solid tumor amongst patients between 15 and 35 years of age. They are also one of the types of tumor with the highest cure rate, due to their high sensitivity to cisplatin based chemotherapy. Nonetheless, around 15-20% of metastatic patients will not have curative options after a relapse on the first and second line. This proves that new therapeutic options for these refractory GCTs patients need to be developed. This article offers a bibliographic review of all studies using targeted treatment or immunotherapy for refractory GCTs patients.es_ES
dc.identifier.citationGalvez-Carvajal L, Sanchez-Muñoz A, Ribelles N, Saez M, Baena J, Ruiz S, Ithurbisquy C, Alba E. Targeted treatment approaches in refractory germ cell tumors. Crit Rev Oncol Hematol. 2019 Nov;143:130-138. doi: 10.1016/j.critrevonc.2019.09.005. Epub 2019 Sep 25. PMID: 31634730.es_ES
dc.identifier.doi10.1016/j.critrevonc.2019.09.005
dc.identifier.urihttps://hdl.handle.net/10630/31250
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCélulas germinales - Tumoreses_ES
dc.subject.otherGerm cell tumorses_ES
dc.subject.otherTargeted therapyes_ES
dc.subject.otherTesticular tumorses_ES
dc.titleTargeted treatment approaches in refractory germ cell tumorses_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationa2d651f3-b8d2-4a50-8365-f94faea30fca
relation.isAuthorOfPublication1e58df71-b337-4856-a5e8-02f8c2e8792b
relation.isAuthorOfPublication.latestForDiscoverya2d651f3-b8d2-4a50-8365-f94faea30fca

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-s2.0-S1040842819301866-main.pdf
Size:
523.77 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Artículos